Sudarshan Chemical Industries (506655) M&A announcement summary
Event summary combining transcript, slides, and related documents.
M&A announcement summary
11 Oct, 2026Deal rationale and strategic fit
Acquisition expands the global footprint: descriptions cite 17 manufacturing sites in 11 countries and 33 stock points, as well as operations across 19 sites worldwide.
Heubach adds pigment technology, IP, customer relationships and strength in coatings and inks; complementary strengths include low-cost Indian manufacturing and plastics.
Heubach reported 2023 revenue of ~EUR 900 million and has a legacy spanning more than 200 years.
The acquisition supports global asset expansion and access to major markets, particularly Europe and the Americas.
Financial terms and conditions
Purchase price is Rs 1,180 Cr / EUR 127.5 million on a debt-free basis; definitive agreements were signed October 11, 2024, using asset purchases for insolvent German entities and share purchases for solvent entities.
Additional planned cash infusion of Rs 925 Cr / EUR 100 million covers working capital, restructuring, regulatory requirements and integration buffers; funding needs are expected over one year.
Funding is planned through a mix of debt and equity, with the board to finalize the plan.
Existing working capital transfers with the acquired operations; management expects no major working-capital infusion.
Synergies and expected cost savings
Value-capture levers include SG&A, manufacturing and procurement efficiencies, operational restructuring, working-capital and cash management, and recovery of lost volumes.
SG&A plans include IT, finance, HR and administrative operations, with potential Global Business Services use for non-critical roles; IT integration and procurement optimization are also targeted.
Some SG&A and manufacturing savings are expected in year one; significant value capture is targeted within a year and full benefits within two years.
Plans include restructuring underperforming sites and shifting select production.
Latest events from Sudarshan Chemical Industries
- Q1 FY25 saw higher revenue, EBITDA, and margins, with normalized profit and improved leverage.506655
Q1 24/25 - Record pigment sales lifted margins as Heubach acquisition advanced.506655
Q2 24/25 - Q3 FY25 saw strong revenue growth, margin gains, and progress on the Heubach acquisition despite costs.506655
Q3 24/25 - Heubach lifts FY25 sales and adjusted EBITDA, with profitability targets hinging on integration.506655
Q4 24/25 - Q1 FY26 revenue rose to ₹2,507 crore with EBITDA up, but margins and net profit ratio declined.506655
Q1 25/26 - Q2 sales grew despite destocking; Heubach guidance fell as integration advanced.506655
Q2 25/26 - Weak demand drove a consolidated loss, while cost savings and restocking signal recovery.506655
Q3 25/26 - Q4 growth, acquired-group recovery and debt reduction support FY27 plans amid cost risks.506655
Q4 25/26 - Q1 FY27 saw robust revenue, EBITDA, and profit growth, with improved capital efficiency and restructuring.506655
Q1 26/27